Microalbuminuria in Type-2 Diabetes Mellitus; the tip of iceberg of diabetic complications

被引:42
作者
Ahmad, Tauseef [1 ]
Ulhaq, Imran [1 ]
Mawani, Minaz [1 ]
Islam, Najmul [1 ]
机构
[1] Aga Khan Univ Hosp, Dept Med, Endocrinol Sect, Karachi, Pakistan
关键词
Complications; Hypertension; Microalbuminuria; Type-2; diabetes; HIGH PREVALENCE; NEPHROPATHY; DYSLIPIDEMIA; ALBUMINURIA; DISEASE; DEATH; RISK;
D O I
10.12669/pjms.333.12537
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Objective: To determine the prevalence of microalbuminuria and its association with hypertension and other diabetic complications among Type-2 diabetic patients attending at Aga Khan University Hospital Karachi. Methods: 1280 Type-2 diabetes patients who visited the outpatient department of Aga Khan University Hospital from September 2014 to August 2016 were included in the study. Microalbuminuria was diagnosed if spot-urinary rnicroalbumin excretion was confirmed to be more than 20mg/l. Hypertension was diagnosed if BP >140/90 or already on antihypertensive medications. Other demographic, clinical and laboratory data were also recorded. Results: Microalbuminuria was diagnosed in 404(31.56%) patients and among these albuminuric patients 335(82.9%) had hypertension. They were also dyslipidemic, having raised triglyceride levels, lower HDL levels, with more prevalence of background diabetic retinopathy and peripheral neuropathy. They also showed higher HbA1C levels and longer duration of diabetes. Conclusion: The prevalence of the microalbuminuria in our patients with Type-2 diabetes is 31.56% and is not only an early sign of diabetic nephropathy but also a host of other diabetic complications and should be dealt early with strict control of their hyperglycemia and hypertension to help prevent the future complications.
引用
收藏
页码:519 / 523
页数:5
相关论文
共 18 条
[1]
Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64) [J].
Adler, AI ;
Stevens, RJ ;
Manley, SE ;
Bilous, RW ;
Cull, CA ;
Holman, RR .
KIDNEY INTERNATIONAL, 2003, 63 (01) :225-232
[2]
Alrawahi Abdulhakeem Hamood, 2012, Oman Med J, V27, P212, DOI 10.5001/omj.2012.48
[3]
American Diabetes Association, 2017, Diabetes Care, V40, pS88
[4]
Ansar MM, 2017, NEPHROUROL MON, V9, DOI [10.5812/numonthly.40031, DOI 10.5812/NUMONTHLY.40031]
[5]
Diabetic dyslipidaemia in Asian populations in the Western Pacific Region: What we know and don't know [J].
Chan, Juliana C. N. ;
Chan, Siew Pheng ;
Deerochanawong, Chaicharn ;
Go, Ruby T. ;
Lee, Kok-Onn ;
Ma, Ronald Ching-Wan ;
Pan, Chang-Yu ;
Sheu, Wayne H-H. ;
Barter, Philip .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 94 (01) :1-13
[6]
Diabetic Dyslipidemia and Atherosclerosis: Evidence from Clinical Trials [J].
Farmer, John A. .
CURRENT DIABETES REPORTS, 2008, 8 (01) :71-77
[7]
Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial [J].
Gde, Peter ;
Oellgaard, Jens ;
Carstensen, Bendix ;
Rossing, Peter ;
Lund-Andersen, Henrik ;
Parving, Hans-Henrik ;
Pedersen, Oluf .
DIABETOLOGIA, 2016, 59 (11) :2298-2307
[8]
Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals [J].
Gerstein, HC ;
Mann, JFE ;
Yi, QL ;
Zinman, B ;
Dinneen, SF ;
Hoogwerf, B ;
Hallé, JP ;
Young, J ;
Rashkow, A ;
Joyce, C ;
Nawaz, S ;
Yusuf, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (04) :421-426
[9]
Ginter E, 2013, ADV EXP MED BIOL, V771, P35
[10]
Death, end-stage renal disease and renal function decline in patients with diabetic nephropathy in French cohorts of type 1 and type 2 diabetes [J].
Hadjadj, Samy ;
Cariou, Bertrand ;
Fumeron, Frederic ;
Gand, Elise ;
Charpentier, Guillaume ;
Roussel, Ronan ;
Kasmi, Ahmed-Amine ;
Gautier, Jean-Francois ;
Mohammedi, Kammel ;
Gourdy, Pierre ;
Saulnier, Pierre-Jean ;
Feigerlova, Eva ;
Marre, Michel .
DIABETOLOGIA, 2016, 59 (01) :208-216